Review finds reinforced staplers linked to fewer pancreatic leaks after surgery
A network analysis compared ways to close and protect the pancreas after distal pancreatectomy, but residual risk remained with every approach.
High evidenceReviewSome caution advised
Medical disclaimer: This article summarizes research findings and is for informational purposes only. It is not medical advice.
Editorial illustration — not from the study.
The review used a Bayesian network meta-analysis to compare several ways of managing the remaining pancreatic tissue after surgery. These included closure with sutures or staplers, coverage with mesh or a patient's own tissue, and reinforced staplers.
Reinforced staplers ranked highest for reducing clinically relevant postoperative pancreatic fistula, but the analysis did not show that any strategy removed this complication. The researchers described an ongoing residual risk as a pancreatic fistula "grey zone."
What the review examined
The researchers examined which pancreatic-stump management strategies may be associated with better outcomes after distal pancreatectomy. They combined 20 randomized controlled trials with a total of 2,868 patients in a Bayesian network meta-analysis. The strategies were grouped by the main closure method, whether additional coverage was used, and whether staplers were reinforced. The main outcome was clinically relevant postoperative pancreatic fistula. Other outcomes included biochemical leakage, abdominal fluid collections, abscesses, blood loss, operating time, hospital stay, and overall complications.
What the evidence shows
Compared with suture-based closure, reinforced staplers were associated with a lower risk of clinically relevant postoperative pancreatic fistula: odds ratio 0.41, with a 95% credible interval of 0.17 to 0.95. Reinforced staplers also ranked highest among the strategies assessed for this outcome, although ranking results do not by themselves establish that one approach is superior in every setting. For intra-abdominal fluid collection, autologous patch techniques were associated with lower odds: odds ratio 0.15 for an autologous patch used with a stapler and 0.28 for an autologous patch used with sutures. Clinically relevant pancreatic fistula continued to occur with all evaluated strategies.
Who this may apply to
The findings may be relevant to populations similar to the patients included in the randomized trials: people undergoing distal pancreatectomy. They do not necessarily apply to other pancreatic operations, other types of abdominal surgery, or patients with different surgical risks. This review compares evidence about techniques; it does not establish that one approach is appropriate for every patient or surgical setting.
What this could mean
Pancreatic fistula is described in the abstract as the most common and clinically significant complication after distal pancreatectomy. These findings may help researchers and clinicians compare surgical techniques, but they do not identify a universally optimal method or remove the complication's residual risk. The results concern patients undergoing a specific pancreatic operation and may not apply to other surgeries or to people who have not had distal pancreatectomy.
Limitations & evidence assessment
The abstract states that the optimal strategy remains uncertain and that clinically relevant pancreatic fistula persisted across all approaches. A network meta-analysis can involve indirect comparisons between techniques that were not tested directly against one another in every trial, and differences among the 20 trials may affect the results. The abstract provides limited information about the individual trials, such as their methods, follow-up periods, patient characteristics, and risk of bias. Therefore, the strength of the rankings and their consistency across hospitals and surgical settings are uncertain.
Why this evidence level: Meta-analysis pooling multiple studies sits at the top of common evidence hierarchies.
Evidence levels are editorial estimates derived from study metadata — they are not clinical appraisals.
// Source
Annals of Hepato-Biliary-Pancreatic Surgery · 2026 · DOI: 10.14701/ahbps.26-106
This review analyzed human studies comparing two treatments given before surgery for locally advanced esophageal or esophagogastric junction adenocarcinoma: FLOT chemotherapy and CROSS chemoradiotherapy. The pooled estimate favored FLOT for overall survival, but the groups had similar three-year survival, tumor response, surgical margins, and several major perioperative outcomes.
A systematic review examined whether Passiflora edulis, commonly known as passion fruit, is linked with lower blood pressure. It included six preclinical studies and two human trials; the animal and laboratory findings were generally more extensive than the human evidence. The authors reported possible blood-pressure reductions but emphasized that the human studies were small, varied in the extracts used, and short in duration.
Researchers studied 96 people with high-risk, locally advanced rectal cancer in a single-center phase II clinical trial. The treatment combined chemotherapy, short-course radiation, and a targeted drug selected for each study cohort. Overall, 40% had a complete response, but the study did not establish how this approach compares with other treatments.
